12:41 PM EDT, 07/23/2024 (MT Newswires) -- Keurig Dr Pepper ( KDP ) is poised to have a weak Q2 but with "sequential improvement," although actual results may be lower than scanner data suggests, RBC Capital Markets said in a preview note Tuesday.

H1 2024 was set up for margin expansion, while H2 is expected to focus on topline growth with stronger growth drivers anticipated, the investment firm said.

Risks include lengthy stay-at-home orders lowering on-premise sales, increased government regulation on soft drink consumption and loss of allied brands, the RBC analysts said.

RBC retained its outperform rating and a $41 price target for Keurig Dr Pepper ( KDP ).

Price: 32.74, Change: -0.09, Percent Change: -0.27